Back to Agenda
S21 : Exploring IRBs with a Global Twist!
Session Chair(s)
Kiyomi Hirayama, PhD
Senior Director, Quality Management Unit Japan Development
Japan
Speaker(s)
Jan Hewett, BSN, JD
FDA, United States
Regulatory Counsel for Policy, OSI, CDER
Rebecca Boesenberg
Novartis Pharmaceuticals, Australia
Study Start-up Team Lead, AUS & NZ, Study and Site Operations
IRB in Taiwan - Collaborative IRB Process and IRB Inspection
Fung-Wei Chang
Taiwan Association of Institutional Review Boards, Taiwan
President
Naoto Uemura, MD, PhD
Oita University Faculty of Medicine, Japan
Vice Dean and Professor, Department of Clinical Pharmacology and Therapeutics
Yusuke Fukuda
Ministry of Health, Labour and Welfare (MHLW), Japan
Dupty Director, Pharmaceutical Evaluationand Management Division
Have an account?